Showing 2,221 - 2,240 results of 18,040 for search 'significantly ((a decrease) OR (linear decrease))', query time: 0.51s Refine Results
  1. 2221
  2. 2222
  3. 2223
  4. 2224

    A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

    Published 2025
    “…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [<sup>68</sup>Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”
  5. 2225

    A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

    Published 2025
    “…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [<sup>68</sup>Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”
  6. 2226
  7. 2227

    Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... by Jiří Plášek (21805048)

    Published 2025
    “…Background<p>Secretoneurin (SN) is a neuropeptide that counterbalances disorders of cell calcium cycling via calmodulin and thus may be involved in arrhythmogenesis. …”
  8. 2228
  9. 2229
  10. 2230

    Initial participants by wave*. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  11. 2231

    General characteristics of research participants. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  12. 2232
  13. 2233

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  14. 2234

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  15. 2235
  16. 2236
  17. 2237
  18. 2238
  19. 2239
  20. 2240